DCF — MONMOUTH MEDICAL CENTER SOUTHERN CAM
Enterprise Value: $-348.6M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-348.6M
Enterprise Value
$-107.4M
PV of Cash Flows
$-241.2M
PV of Terminal Value
$-388.5M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $132.8M | $-23.3M | -18.0% | $-28.9M | $-26.3M |
| Year 2 | $136.8M | $-22.6M | -17.0% | $-28.4M | $-23.5M |
| Year 3 | $140.9M | $-21.9M | -16.0% | $-27.8M | $-20.9M |
| Year 4 | $145.1M | $-21.8M | -15.0% | $-28.0M | $-19.1M |
| Year 5 | $149.4M | $-22.1M | -15.0% | $-28.4M | $-17.6M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-348.6M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$128.9M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.18036336880546303
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5